13 research outputs found

    Global view of MDA progress and projection by programme steps, 2000–2021 (updated from [2]).

    No full text
    <p>Global view of MDA progress and projection by programme steps, 2000–2021 (updated from <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0003328#pntd.0003328-WHO2" target="_blank">[2]</a>).</p

    Strategy of the global programme to eliminate lymphatic filariasis.

    No full text
    <p>Interrupting transmission through mass drug administration (MDA) and morbidity management and disability prevention (MMDP) in populations with LF <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0003328#pntd.0003328-WHO9" target="_blank">[21]</a>.</p

    Selected opportunities for integrating lymphatic filariasis activities into programmes for other diseases [21].

    No full text
    <p>Selected opportunities for integrating lymphatic filariasis activities into programmes for other diseases <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0003328#pntd.0003328-WHO9" target="_blank">[21]</a>.</p

    Tanzania drug acquisition (in drug units,<sup>*</sup> FY Oct. 2010–Sept. 2011).<sup>**</sup>

    No full text
    <p>* The tool also allowed users to display the monetary value of medicines, instead of the drug units.</p><p>** ALB = albendazole; GSK = GlaxoSmithKline; ITI = International Trachoma Initiative; IVM = ivermectin; POS = pediatric oral suspension; PZQ = praziquantel; TEO = tetracycline eye ointment; USAID = United States Agency for International Development; ZMAX = zithromax.</p
    corecore